Skip to content
Screener

Acrivon Therapeutics, Inc. ACRV Q2 2026 earnings

Reported August 12, 2026 · After market close

EPS-$0.43Beat by $0.07
Revenue estimate$386.3K
EPS estimate-$0.50

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$504.3K
EPS estimate-$0.45

FAQ

When did Acrivon Therapeutics, Inc. report Q2 2026 earnings?
Acrivon Therapeutics, Inc. (ACRV) reported Q2 2026 earnings on August 12, 2026 after market close.
What were Acrivon Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Acrivon Therapeutics, Inc. reported eps of $-0.43 for Q2 2026.
Did Acrivon Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.50 by $0.07.
How did Acrivon Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 21.8% from $-0.55.
Where can I find Acrivon Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-346859) and the 10-Q periodic report (0001193125-26-346819) directly on SEC EDGAR. The filing index links above go to sec.gov.